Zevra Therapeutics
ZVRA
ZVRA
109 hedge funds and large institutions have $271M invested in Zevra Therapeutics in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 109 → 109 (0)
4% less capital invested
Capital invested by funds: $283M → $271M (-$11.6M)
46% less call options, than puts
Call options by funds: $2.76M | Put options by funds: $5.07M
Holders
109
Holding in Top 10
5
Calls
$2.76M
Puts
$5.07M
Top Buyers
| 1 | +$5.48M | |
| 2 | +$4.86M | |
| 3 | +$4.62M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$4.51M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$3.57M |
Top Sellers
| 1 | -$6.5M | |
| 2 | -$4.21M | |
| 3 | -$2.89M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.44M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.35M |
